Malignant neoplasm of cecum
ICD-10 C18.0 is a billable code used to indicate a diagnosis of malignant neoplasm of cecum.
C18.0 refers to a malignant neoplasm located in the cecum, which is the first part of the large intestine. This type of cancer is part of the broader category of colorectal cancer, which is characterized by the uncontrolled growth of abnormal cells in the colon or rectum. The cecum is particularly susceptible to adenocarcinomas, which are the most common type of colorectal cancer. Risk factors include age, family history, certain genetic syndromes, and lifestyle factors such as diet and physical inactivity. Symptoms may include abdominal pain, changes in bowel habits, and unexplained weight loss. Screening for colorectal cancer typically involves colonoscopy, which allows for direct visualization and potential biopsy of suspicious lesions. Staging of cecal cancer is crucial for determining treatment options and prognosis, with staging systems such as the AJCC (American Joint Committee on Cancer) being commonly used. Additionally, the presence of microsatellite instability (MSI) can influence treatment decisions, particularly regarding immunotherapy. Surgical approaches often involve resection of the affected segment of the bowel, and may include procedures such as hemicolectomy or total colectomy, depending on the extent of the disease.
Detailed pathology reports, imaging studies, and treatment plans are essential.
Initial diagnosis, staging, and treatment planning for cecal cancer.
Ensure accurate coding of any neoadjuvant or adjuvant therapies.
Endoscopy reports, biopsy results, and patient history.
Screening colonoscopies, polypectomies, and follow-up care.
Document any findings related to polyps or other lesions in the cecum.
Used for resection of the cecum in cases of malignant neoplasm.
Operative report detailing the procedure and findings.
Oncology and surgery specialties should coordinate documentation.
Common symptoms include abdominal pain, changes in bowel habits, unexplained weight loss, and anemia. Some patients may also experience bowel obstruction.
